Compare AbbVie Inc (ABBV) vs Gogoro Inc (GGR) Price & Performance

AbbVie IncTrade

Gogoro IncTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Gogoro Inc — how do they compare? AbbVie Inc trades at $248.94 (market cap $441.94B), while Gogoro Inc trades at $2.63 (market cap $52.19M). The key difference: AbbVie Inc is far larger — about 8467.9× Gogoro Inc's market cap, and AbbVie Inc pays a 2.77% dividend while Gogoro Inc pays none. Which is the better fit depends on your goals.

	ABBV	GGR
Market Cap	$441.94B	$52.19M
Sector	Health	Technology
52-Week High	$263.58	$7.50
52-Week Low	$197.38	$2.55
Enterprise Value	$506.19B	$354.63M
Dividend Yield	2.77%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $249.9, up 0.8% on the day, with strong analyst support (29 Buy, 1 Sell) and a $278.69 consensus price target. Recent quarterly earnings have consistently beaten estimates, driven by robust immunology drug sales. The stock shows a bullish technical trend, supported by moving averages, and the company maintains solid cash flow and dividend payments.

Outlook is positive with revenue growth and pipeline advancements, though high P/E and debt levels pose risks. The stock offers a compelling buy case for growth and income investors, balanced by execution and patent expiry challenges ahead.

Gogoro Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 1 day agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

GGR

View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Gogoro Inc

Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.